Preparation, characterization and in vivo assessment of the bioavailability of glycyrrhizic acid microparticles by supercritical anti-solvent process.

Xiaoyu Sui,Wei Wei,Lei Yang,Yuangang Zu,Chunjian Zhao,Lin Zhang,Fengjian Yang,Zhonghua Zhang
DOI: https://doi.org/10.1016/j.ijpharm.2011.12.007
IF: 6.51
2012-01-01
International Journal of Pharmaceutics
Abstract:In this study, glycyrrhizic acid (GA) microparticles were successfully prepared using a supercritical anti-solvent (SAS) process. Carbon dioxide and ethanol were used as the anti-solvent and solvent, respectively. The influences of several process parameters on the mean particle size (MPS), particle size distribution (PSD) and total yield were investigated. Processed particle sizes gradually decreased as temperature and solution flow rate increased. In addition, processed particle sizes increased from 119 to 205nm as GA concentration increased. However, CO2 flow rate did not significantly affect particle size. The optimized process conditions were applied, those included temperature (65°C), pressure (250bar), CO2 and drug solution flow rate (15 and 8mLmin−1), drug concentration in ethanol (20mgmL−1). Microparticles with a span of PSD ranging from 95 and 174nm, MPS of 128nm were obtained, and total yield was 63.5%. The X-ray diffraction patterns of glycyrrhizic acid microparticles show apparent amorphous nature. Fourier transform infrared (FT-IR) spectroscopy results show that no chemical structural changes occurred. The in vitro dissolution tests showed that the GA microparticles exhibited great enhancement of dissolution performance when compared to GA original drug. Furthermore, the in vivo studies revealed that the microparticles provided improved pharmacokinetic parameter after oral administration to rats as compared with original drug.
What problem does this paper attempt to address?